Oslomed – Clinical Trial Site Organization

Clinical Research Site Kraków

Together We Deliver
Clinical Excellence
for You

At Oslomed, our mission is to facilitate transparent communication among patients, sponsors, and our medical team while providing reliable partnerships for pharmaceutical companies and Clinical Research Organizations.

7,200 Patient Database
100% Commitment to Every Project
20+ Physicians at Oslomed

Oslomed simplifies clinical trial execution in Poland. We offer sponsors and CROs rapid decisions, efficient recruitment in Phase II-IV trials — without unnecessary bureaucracy.

We Simplify Clinical Trials from Site Selection to Study Close-Out

Oslomed partners with pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs) as a partner in executing Phase II-IV clinical trials in Poland.

Clinical Trial Execution

From feasibility assessment, through active trial conduct to final documentation handover.

  • Feasibility Response – recruitment capability analysis within 24 working hours
  • Patient Recruitment – active enrollment strategies
  • Site Initiation – team training and operational readiness
  • Trial Conduct – participant care and protocol adherence
  • CRA Collaboration – documentation readiness and support during monitoring visits
  • Study Close-Out – documentation finalization and archiving

Technology Readiness

Flexible integration with sponsor-selected systems

  • Flexible Integration – we work with systems proposed by sponsor/CRO
  • EMR Integration Ready - open to electronic medical records
  • eICF Implementation – ready to deploy electronic informed consent solutions
  • Dedicated IT Infrastructure – stable connectivity

Patient Recruitment: The Biggest Challenge in Clinical Trials

Industry research shows that 80% of clinical trials experience recruitment delays, with the average delay costing sponsors €600,000 to €8 million per month. Moreover, 37% of trial sites consistently under-enroll, and 11% fail to recruit any patients at all—forcing sponsors to activate additional sites and extend timelines.

Oslomed's Solution

While many sites face recruitment challenges, Oslomed stands apart with direct patient access through specialized outpatient clinics and a robust patient database. Our diverse, established patient population across multiple therapeutic areas allows for rapid screening and enrollment—reducing time-to-first-patient and accelerating study timelines.

How Does Oslomed Solve This Problem?

As a research site integrated with an active specialty clinic, we have direct access to an active patient database with medical history. Therefore, this provides sponsors with predictability and shortens time to first participant.

  • Clinic Database – 8,000+ annual visits across 12 medical specialties
  • Medical Record Access – rapid candidate pre-screening
  • Existing Physician-Patient Relationship – trust facilitates clinical trial enrollment
  • Rapid Identification – we analyze our database before launching external campaigns
  • Continuity of Care – patients can return to our clinic after trial completion

Therapeutic Areas

Experienced investigators conducting Phase II-IV projects in key therapeutic areas. Team of Principal Investigators and Coordinators with experience in international trials and access to comprehensive diagnostic infrastructure, backed by qualified medical and administrative support staff.

Active Therapeutic Areas

Therapeutic areas with experienced investigators and coordinator teams.

Gastroenterology

Indications: Inflammatory Bowel Disease, Crohn's disease, ulcerative colitis, irritable bowel syndrome, GERD, celiac disease.

Dermatology

Indications: Psoriasis (plaque, scalp, palmoplantar), atopic dermatitis, hidradenitis suppurativa, acne vulgaris.

Cardiovascular

Indications: Heart failure, atrial fibrillation, arterial hypertension, dyslipidemia, coronary artery disease.

Rheumatology and Immunology

Indications: Rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, acute low back pain, systemic lupus erythematosus, osteoarthritis, osteoporosis.

Pulmonology/Respiratory Diseases

Indications: COPD, severe asthma, idiopathic pulmonary fibrosis, pulmonary arterial hypertension.

Neurology

Indications: Alzheimer's disease, Parkinson's disease, sleep disorders, migraine, stroke, peripheral neuropathies, epilepsy.

Oncology

Indications: Breast cancer, NSCLC, prostate cancer.

Endocrinology/Metabolic

Indications: Type 2 diabetes, chronic kidney disease, obesity, thyroid disorders, nonalcoholic steatohepatitis, neuroendocrine tumors.

Development Areas – Expanding Expertise

Therapeutic areas where we are actively building our Principal Investigator team and adapting our infrastructure through partnerships with clinics. We are expanding our network of collaborating physicians to ensure qualified personnel and enhanced patient recruitment capacity for sponsor projects.

Psychiatry/Mental Health & Psychedelics

Target indications: Major Depressive Disorder, schizophrenia, anxiety disorders, ADHD, bipolar disorder.

Gynecology and Women's Health

Target indications: Endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), menopause, contraception.

Other Therapeutic Areas?

Don't see your therapeutic area? Contact us. We'll assess recruitment possibilities and present an action plan within days.

Contact Us

Quality and Trial Oversight

As a small, independent site, we combine personal commitment with rigorous quality control processes. Additionally, every sponsor has direct contact with the principal investigator and coordinator managing their trial. No bureaucracy, no delays.

<48h
EDC Data Entry
<48h
Query Resolution
<24h
Adverse Event Reporting

Our Approach to Quality

At Oslomed, every sponsor has direct contact with the principal investigator and coordinator managing their study. In addition, we answer the phone on the first ring and respond to emails the same day. As a result, problems are solved immediately, not in a few days.

Quality through commitment: Our quality system isn't bureaucratic machinery — it's the work style of a tight-knit, motivated team that treats every trial as a personal priority. Moreover, rapid response, flexibility, and complete transparency are our natural advantages.

How Our Site Delivers Quality

Data and Documentation Quality

  • Timely Data Entry and Query Resolution
    Visit data are entered into electronic data capture (EDC) systems within 48 hours, with data queries addressed promptly within the same timeframe.
  • Source Data Verification
    Key variables and endpoints are cross-checked against patient source records before closing each visit.
  • Comprehensive Visit Documentation
    Informed consent, inclusion/exclusion criteria, and all required visit documentation are verified at screening and at every visit.
  • Complete Safety and Medication Records
    All concomitant medications and adverse events are recorded in both source notes and the database prior to finalizing each visit.

Participant Safety and Compliance

  • Primarily, we report adverse events within 24 hours and serious adverse events immediately, following the protocol and regulations.
  • Furthermore, we provide immediate support for study participants with clear escalation paths to investigators.
  • Lastly, we maintain inspection readiness with checklists, internal spot checks, and corrective–preventive actions when needed.

Training and Team Competence

Ensuring every team member has the necessary knowledge:

  • GCP training for all study personnel
  • Protocol-specific training with documented attendance
  • Refresher training as protocols are amended
  • Complete training records in Trial Master File

Standard Operating Procedures

Written procedures covering:

  • Informed consent process
  • Participant screening and recruitment
  • Investigational product management
  • Adverse event reporting
  • And more — a complete suite of additional critical SOPs

Regular reviews, version control, training documentation

Clinical Trial Lifecycle at Oslomed

1. Feasibility Assessment
24h working hours response time
2. Site Activation
60-90 days from site selection
3. Recruitment
Screening, informed consent, enrollment
4. Trial Conduct
Protocol compliance, <48h working hours data entry in EDC & query resolution
5. Close-Out
Final reports, documentation archiving

Small Site, Big Commitment

Quality control, personal commitment, immediate response. We answer the phone on the first ring. No delays. No unnecessary management layers.

Contact Us

Contact Us

Are you a sponsor or CRO interested in collaboration?
Contact our clinical trials team.

Address

Pleszowska 23
31-228 Kraków
Poland

Business Hours

Monday – Friday: 9:00 AM – 8:00 PM
Saturday – Sunday: Closed

We respond to email inquiries within 24 business hours

SEO Keywords

Clinical trials: clinical trials Krakow, clinical trial site Poland, clinical research center Poland, sponsor collaboration, pharmaceutical trials, ICH-GCP, FDA trials, EMA clinical trials, trial site Poland

Recruitment and processes: patient recruitment clinical trials, clinical trial feasibility, site selection, phase II III IV trials, multicenter trials, trial monitoring, patient enrollment, patient retention, clinical trial screening

Specialists and trials: dermatologist clinical trials, cardiologist clinical trials, gastroenterologist clinical trials, rheumatologist clinical trials, pulmonologist clinical trials, neurologist clinical trials, urologist clinical trials, endocrinologist clinical trials, gynecologist clinical trials, orthopedist clinical trials, oncologist clinical trials, diabetologist clinical trials, allergist clinical trials

Therapeutic areas: dermatology trials, cardiology trials, gastroenterology trials, rheumatology trials, pulmonology trials, neurology trials, urology trials, endocrinology trials, gynecology trials, orthopedic trials, oncology trials, diabetology trials, allergology trials

Disease units - dermatology: psoriasis clinical trials, atopic dermatitis trials, acne clinical trials, vitiligo trials, AD clinical trials

Disease units - cardiology: hypertension trials, atrial fibrillation trials, coronary artery disease trials, heart failure trials

Disease units - gastroenterology: Crohn's disease clinical trials, ulcerative colitis trials, UC trials, gastroesophageal reflux trials, IBD clinical trials

Disease units - rheumatology: rheumatoid arthritis trials, RA clinical trials, ankylosing spondylitis trials, AS trials, psoriatic arthritis trials, lupus clinical trials

Disease units - pulmonology: asthma clinical trials, COPD clinical trials, idiopathic pulmonary fibrosis trials, cystic fibrosis trials

Disease units - neurology: Parkinson's disease trials, multiple sclerosis clinical trials, MS trials, epilepsy clinical trials, Alzheimer's disease trials, migraine clinical trials

Disease units - other: type 2 diabetes trials, benign prostatic hyperplasia trials, endometriosis clinical trials, osteoarthritis trials, osteoporosis clinical trials, obesity clinical trials

Compliance and regulations: investigational product, informed consent, adverse events, safety monitoring, regulatory compliance, good clinical practice, clinical trial documentation, clinical trial audits, pharmacokinetics

Technology and partners: biotechnology, principal investigator, clinical trial coordinator, CRO Poland, drug development, post-marketing trials